Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by CCAbbott888on Apr 29, 2019 10:48am
227 Views
Post# 29683208

RE:RE:Three thoughts on the rights offer

RE:RE:Three thoughts on the rights offer
james700 wrote:
CCABBOTT888 The one BIG thing you are missing is that the current shareholders equity will be reduced to 3% from 100%. Yes, you can participate but only 1/3 of your shares will qualify because of the $75M cap. That pool off shares will only have 20% of the equity. Thomvest and friends will reverse split in June and flip the company to a waiting deal, walking away with 80% of the profits...
james700  I understand your point, which I already articulated in my seeking alpha article on April 17  However, the equity value of the current 736M share holders is already mostly wiped out on April 23 when the private placement and $239M debt conversion to equity, not 'will be reduced' as you stated.  It's ALREADY done!

Your understanding of the rights offer (only 1/3 of your shares will qualify) is INCORRECT.  Please refer to my previous reply to your post here

Barring AMF intervention (which is yet to be seen), the refinancing plan has already taken place and the equity structure of this company has already re-structured.
Bullboard Posts